The FERO Foundation and the Clínic-IDIBAPS join Forces for Cancer Research
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Program...
Unit News from Hepatic Oncology
Researchers at the Hospital Clínic-IDIBAPS participate in the new guidelines on intrahepatic cholangiocarcinoma
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the sec...
Mindfulness has beneficial effects in people with cancer
Mindfulness has shown many benefits during the cancer process. Over 450 people have already participated in the ONCOR programme of the Clínic Barce...
How to alleviate the side effects of chemotherapy?
Some of the most common side effects of chemotherapy are fatigue, nausea and vomiting. To alleviate them, you should rest, stay hydrated and mainta...
8 tips to prevent cancer
Avoiding tobacco use, leading a healthy lifestyle, protecting yourself from the sun and vaccination against infection by certain viruses are some f...
Assessing the mortality rate for patients with liver cancer not vaccinated against COVID-19
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.
Dra. Maria Reig: “Over the last 15 years, there has been a revolution in the treatment of liver cance
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
Two articles review current knowledge on the management of hepatocellular carcinoma
Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which t...
EuCanImage: Next-generation artificial intelligence in oncology
Reserachers of Hospital Clínic-IDIBAPS participate in EuCanImage, a project from the Horizon 2020 program that will build a federated and scalable...